학술논문

Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆
Document Type
Article
Source
In Annals of Oncology October 2020 31(10):1350-1358
Subject
Breast tumors
Language
ISSN
0923-7534